,5 Immune class switching with other psoriasis biologics, such as TNF-alpha and IL-23 inhibitors, does occur, though it is documented less frequently than with IL-17i suggesting a less robust risk of immune deviation.5 The gene discussed is TNF; the disease is psoriasis.